Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stun Medical is a South Korean aesthetic medicine company specializing in the development, manufacture, and distribution of advanced dermatological and cosmetic solutions. Headquartered in Seoul, the company provides a diverse portfolio of products, including hyaluronic acid fillers under the SOSUM and BONETTA brands, botulinum toxin products, and innovative skin boosters. Stun Medical is recognized for its proprietary technologies, such as the Botulinum Peptide and plant-derived exosome formulations used in its PCL Power Booster and BotanicEXO lines. The company maintains a global distribution network, with significant operations in Southeast Asia, Europe, and the United States. By combining clinical expertise with cutting-edge manufacturing, Stun Medical aims to deliver high-quality, safe, and effective treatments for facial rejuvenation and body contouring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stun Medical.